home Go to Doctors Page
ScienceBased Health
1 888 433 4726
  • Doctor
  • Consumer
Facebook Twitter

Free Shipping with Auto-Delivery & Savings up to 20% with a Package Plan

more +
Auto-Delivery & Free Shipping!
Save money and add convenience! Your product(s) will be automatically sent to you each month
Select the "Auto Delivery" box at checkout.
Save Packages:
Save up to 20% & Free Shipping!
Purchase 3-5 bottles: save 5%
Purchase 6-11 bottles: save 12%
Purchase 12+ bottles: save 20%

phone

Menu
  • Products
    • Products A-Z
    • Dry Eye
    • Eye & Whole Body Health
      • OcularProtect® Robust Whole Body Formula
      • OcularEssentials® Whole Body Formula
    • Macular Health Concerns
      • MacularProtect Complete® AREDS-Based Formula & Multinutrient
      • MacularProtect® AREDS-Based Formula
    • Omega-3
    • Optic Nerve Health
    • Retinal Circulation
    • Bone & Joint Health
      • BoneProtect
      • JointProtect
  • Faqs
  • Resources
    • Staying Healthy Newsletter
    • EduFacts Newsletter
    • Product Monographs
    • Educational Links
  • About us
    • Company
    • Advisory Boards
    • Press Releases
    • In the News
    • Events
  • Contact
  • Login
  • View Cart
  • (0)
Facebook Twitter

EduFacts Newsletter

In the news: Modified Med Diet Reduces Retinopathy Risk: Carotenoids Linked to Lower AMD

In the news: Modified Med Diet Reduces Retinopathy Risk: Carotenoids Linked to Lower AMD

In the news: Modified Med Diet Reduces Retinopathy Risk: Carotenoids Linked to Lower AMD

Modified Med Diet Reduces Retinopathy Risk

To date, no clinical trials have specifically evaluated the role of dietary patterns in the incidence of microvascular diabetes complications, according to the investigators of the PREvención con DIeta MEDiterránea or PREDIMED Study. These researchers hypothesized that a nutritional intervention based on the Mediterranean diet (MedDiet) would have a protective effect on diabetic retinopathy and nephropathy. The PREDIMED Study was a multicenter, randomized nutritional intervention trial conducted in a population at high risk for CVD.

This post hoc analysis (1) looked at a cohort of over 3,600 PREDIMED participants with type 2 diabetes who were free of microvascular complications at enrollment. Participants were randomly assigned to one of three dietary interventions: MedDiet supplemented with extra virgin olive oil, MedDiet with mixed nuts, or a low-fat control diet.

During a median follow-up of 6 years, 74 new cases of retinopathy and 168 of nephropathy were identified. The results showed that a MedDiet enhanced with extra virgin olive oil significantly decreased incident diabetic retinopathy by 44% compared to the low-fat control diet (adjusted Hazard Ratio = 0.56, 95% CI, 0.32–0.97).

A relative risk reduction, though non-significant, was also seen for the MedDiet plus nuts vs. the control diet. Unlike the results from some observational studies that found favorable effects of the MedDiet on kidney function, no effects on nephropathy were seen in this analysis.

Carotenoids and Advanced AMD Risk

While the primary analyses of the AREDS2 trial failed to prove a protective effect of lutein/zeaxanthin, a 26% reduction in risk was seen for participants at the bottom 20% of dietary intake of these carotenoids. Given the unlikely occurrence of another large-scale, randomized trial like AREDS2, data from large and long-running prospective cohort studies may be the best evidence we’ll have to evaluate the potentially protective role of lutein/zeaxanthin.

Harvard researchers recently examined associations between carotenoid intakes and AMD in two large, prospective cohorts with repeated dietary assessments who were followed for over two decades (24-26 years) (2). Data was analyzed from more than 63,000 females in the Nurses’ Health Study and 38,600 males in the Health Professionals Follow-Up Study.

The researchers computed predicted plasma carotenoid scores directly from food intake, assessed by repeated food frequency questionnaires.
Associations between predicted plasma carotenoid scores and AMD were determined.

About 2.5% of the participants developed either intermediate or advanced AMD (mostly wet AMD) during the follow-up. Comparing highest vs. lowest quintiles of predicted plasma lutein/zeaxanthin scores showed a risk reduction for advanced AMD of about 40% in both women and men (pooled relative risk comparing extreme quintiles = 0.59; 95%CI, 0.48-0.73; P for trend < .001).

Predicted plasma carotenoid scores for other carotenoids, including β-cryptoxanthin, α- and β-carotene, were associated with a 25% to 35% lower risk of advanced AMD when comparing top and bottom quintiles. No link between carotenoids and intermediate AMD was seen.

The authors point out that α-carotene and β-carotene are found in human RPE and choroid where they could protect against light-induced oxidative damage and locally produced free radicals. While very high dose supplemental β-carotene competitively reduced absorption of lutein/zeaxanthin in AREDS2, consuming a wide variety of fruits and vegetables – i.e. a carotenoid-rich diet – may be a sound public health strategy for reducing the risk of advanced AMD.

References

  1. Diaz-Lopez A, et al. Mediterranean Diet, Retinopathy, Nephropathy, and Microvascular Diabetes Complications: A Post Hoc Analysis of a Randomized Trial. Diabetes Care; Published online before print Sept. 13, 2015.
  2. Wu J, et al. Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration during 2 Decades of Prospective Follow-up. JAMA Ophthalmol. Published online October 8, 2015.
Home  >  General Webpages  >  Resources  >  Edufacts Content  >  EduFacts Scientific Write-ups  > 

Stay Informed

Sign up to get nutrition news, health tips, and product updates.

Please also send me:
EduFacts scientific write-ups (monthly)
Notice of new products and special offers

Your information is never shared with third parties. View our privacy policy

Like Us on Facebook

Follow SBH on Facebook for great health tips, product info and much more.

Our Quality Guarantee

  • Products meet or exceed new GMPs
  • Produced in NSF®-certified facilities
  • Highest quality raw materials utilized
  • Third party testing
  • 30-day money-back guarantee (60 days for HydroEye)
Learn more »

Innovative Nutraceuticals for Eye Health

ABOUT SSL
CERTIFICATES

This site chose VeriSign SSL
for secure e-commerce and
confidential communications.

Home | Feedback | Manufacturing | Privacy Policy | Terms & Conditions | Contact Us

Call us Toll Free 1.888.433.4726. From Outside the US and Canada 281.885.7700
©ScienceBased Health

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

Top